摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,3-二甲基己醛 | 55320-57-5

中文名称
3,3-二甲基己醛
中文别名
——
英文名称
3,3-dimethylhexanal
英文别名
——
3,3-二甲基己醛化学式
CAS
55320-57-5
化学式
C8H16O
mdl
——
分子量
128.214
InChiKey
IHEORNQYISDNQZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 保留指数:
    915.5

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    9
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2912190090

SDS

SDS:e1dc1521bbbf0c629aac17de7fd7f31d
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Novel 11-hydroxy-9-keto-5,6-cis-13,14-cis-prostadienoic acid derivatives
    摘要:
    这份披露描述了某些11-羟基和11-去氧-9-酮(或羟基)-前列腺酸衍生物,可用作支气管扩张剂、降压剂、抗溃疡剂或中间体。
    公开号:
    US04123456A1
  • 作为产物:
    描述:
    4-甲基-3-戊醇 在 palladium on activated charcoal mercury(II) diacetate氢气 作用下, 生成 3,3-二甲基己醛
    参考文献:
    名称:
    The Steric Course of the Claisen Rearrangement
    摘要:
    An infrared study of the stereochemistry attending the Claisen rearrangement of cis- and trans-alpha,gamma-dimethylallyl and two other related vinyl ethers has shown that the reaction produces essentially only trans substituted allylacetaidehydes. The double bond in the o-Claisen rearrangement product of trans-alpha, gamma-dimethylallyl phenyl ether has also been demonstrated by infrared absorption to be predominantly trans. The transition state geometry of the Claisen rearrangement implied by these findings is discussed.
    DOI:
    10.1021/ja01502a057
点击查看最新优质反应信息

文献信息

  • Novel 11-hydroxy-9-keto-5,6-cis-13,14-cis-prostadienoic acid derivatives
    申请人:American Cyanamid Company
    公开号:US04123456A1
    公开(公告)日:1978-10-31
    This disclosure describes certain 11-hydroxy and 11-deoxy-9-keto(or hydroxy)-prostanoic acid derivatives useful as bronchodilators, hypotensive agents, anti-ulcer agents, or as intermediates.
    这份披露描述了某些11-羟基和11-去氧-9-酮(或羟基)-前列腺酸衍生物,可用作支气管扩张剂、降压剂、抗溃疡剂或中间体。
  • Lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates
    申请人:American Cyanamid Company
    公开号:US03932479A1
    公开(公告)日:1976-01-13
    This disclosure describes 3-triphenylmethoxy-1-alkynes, 3-triphenylmethoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates useful as intermediates for the preparation of certain 11-hydroxy- and 11-deoxy-9-keto(or hydroxy)-prostanoic acid derivatives which possess bronchodilator, hypotensive, and anti-ulcer activity.
    本公开揭示了作为制备某些具有支气管扩张剂、降压剂和抗溃疡活性的11-羟基和11-去氧-9-酮(或羟基)-前列腺酸衍生物的中间体的3-三苯甲氧基-1-炔基、3-三苯甲氧基-1-反式-烯基-二烷基铝和锂3-三苯甲氧基-1-反式-烯基-二烷基丙酸铝。
  • 2-Substituted-3,4-epoxycyclopentan-1-ones, and
    申请人:American Cyanamid Company
    公开号:US03966773A1
    公开(公告)日:1976-06-29
    This disclosure describes 2-substituted-3,4-epoxy-cyclopentan-1-ones, 2-substituted-3,4-epoxycyclopentan-1-ols, and various 2-substituted-cyclopentenones useful as intermediates for the preparation of certain 11-hydroxy- and 11-deoxy-9-keto(or hydroxy)-prostanoic acid derivatives which possess bronchodilator, hypotensive, and anti-ulcer activity.
    这份披露描述了2-取代-3,4-环氧基环戊烷-1-酮,2-取代-3,4-环氧基环戊烷-1-醇,以及各种有用的2-取代环戊烯酮,作为制备具有支气管扩张剂、降压和抗溃疡活性的某些11-羟基和11-去氧-9-酮(或羟基)前列腺酸衍生物的中间体。
  • CARBOXYLIC ACID DERIVATIVES AND ADHESION MOLECULE INHIBITORS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
    申请人:TORAY INDUSTRIES, INC.
    公开号:EP1209147A1
    公开(公告)日:2002-05-29
    Prevention or therapy of inflammatory diseases caused by invasion of leukocytes such as monocytes, lymphocytes and eosinophils, by providing a substance which inhibits cell adhesion via an adhesion molecule, especially adhesion molecule VLA-4, is disclosed. A group of carboxylic acid derivatives represented by, for example, and adhesion molecule inhibitors comprising the same as an effective ingredient were provided.
    通过提供一种通过粘附分子抑制细胞粘附的物质,特别是粘附分子VLA-4,来预防或治疗由单核细胞、淋巴细胞和嗜酸性粒细胞侵袭引起的炎症性疾病的方法被揭示。提供了一组由羧酸衍生物代表的粘附分子抑制剂,例如,以其为有效成分的粘附分子抑制剂。
  • MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
    申请人:Navitor Pharmaceuticals, Inc.
    公开号:US20170114080A1
    公开(公告)日:2017-04-27
    The present invention provides compounds, compositions thereof, and methods of using the same.
    本发明提供了化合物、其组合物以及使用相同的方法。
查看更多